Skip to content
Teethgrinder – Lifestyle
Author:
Mentari Therapeutics
Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline
July 22, 2026
Mentari Therapeutics Appoints Industry Veteran Greg Divis as Chief Executive Officer
July 20, 2026